Guillain-Barre syndrome and its treatment

Michael Douglas, John Winer

Research output: Contribution to journalReview article

9 Citations (Scopus)


Guillain-Barré syndrome typically presents with an acute ascending areflexic weakness, progressing over 4 weeks or less. The most common form of the disease is an acute inflammatory demyelinating polyneuropathy, but other forms with primarily axonal pathologies are well documented. The association of Guillain-Barré syndrome with a range of antecedent infections, particularly Campylobacter jejuni enteritis, is also established. A range of serological and neurophysiological investigations can assist in making an accurate diagnosis. Background information about the syndrome and the evidence base for such treatments are discussed herein.
Original languageEnglish
Pages (from-to)1569-1574
Number of pages6
JournalExpert Review of Neurotherapeutics
Issue number10
Publication statusPublished - 1 Oct 2006


Dive into the research topics of 'Guillain-Barre syndrome and its treatment'. Together they form a unique fingerprint.

Cite this